
US-based clinical-stage company Nido Biosciences has announced that is has received $109m in Seed, Series A and Series B financings, …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

